A randomised double-blind two period crossover study to investigate the effect of treatment with repeat doses of a PPAR gamma agonist on the allergen-induced late asthmatic response in subjects with mild asthma compared with repeat doses of placebo.
Phase of Trial: Phase I
Latest Information Update: 20 Oct 2016
At a glance
- Drugs Rosiglitazone (Primary)
- Indications Asthma
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 28 Mar 2007 Status changed from in progress.
- 06 Nov 2006 New trial record.